IRIS UniCatt

Bianchi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.222
NA - Nord America 2.928
AS - Asia 1.361
SA - Sud America 287
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 7.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.888
DE - Germania 1.022
SG - Singapore 519
SE - Svezia 495
CN - Cina 486
IT - Italia 484
BR - Brasile 262
UA - Ucraina 243
PL - Polonia 219
FR - Francia 173
IE - Irlanda 155
ID - Indonesia 105
GB - Regno Unito 102
FI - Finlandia 100
RU - Federazione Russa 89
IN - India 80
BE - Belgio 29
CA - Canada 26
AT - Austria 25
KR - Corea 25
NL - Olanda 25
TR - Turchia 23
HK - Hong Kong 20
JP - Giappone 19
IR - Iran 18
VN - Vietnam 14
CI - Costa d'Avorio 11
MX - Messico 11
CH - Svizzera 10
CZ - Repubblica Ceca 10
CO - Colombia 7
IQ - Iraq 7
PT - Portogallo 7
RO - Romania 7
ES - Italia 6
LK - Sri Lanka 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
AR - Argentina 5
IL - Israele 5
CL - Cile 4
LT - Lituania 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
EG - Egitto 3
EU - Europa 3
PE - Perù 3
PY - Paraguay 3
AL - Albania 2
BD - Bangladesh 2
EC - Ecuador 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GU - Guam 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LV - Lettonia 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 7.834
Salva come PNG Salva come JPEG
Città #
Chandler 613
Singapore 334
Warsaw 199
Ashburn 188
Dublin 144
New York 127
San Mateo 126
Ann Arbor 114
Rome 108
Jakarta 102
Jacksonville 95
Fairfield 93
Wilmington 93
Milan 71
Nanjing 68
Boston 66
Marseille 60
The Dalles 58
Seattle 57
Moscow 56
Woodbridge 50
Princeton 49
Bremen 48
Los Angeles 46
Nürnberg 46
Helsinki 44
Houston 44
Cattolica 41
Dearborn 35
Munich 34
Chicago 33
Frankfurt am Main 32
Zhengzhou 32
Beijing 30
Boardman 28
Hefei 28
Redwood City 28
Brussels 27
Cambridge 27
Lawrence 27
Hyderabad 26
Nanchang 25
Seoul 24
Mountain View 23
Nuremberg 23
São Paulo 23
North Bergen 21
University Park 21
Norwalk 19
Hong Kong 18
Hangzhou 17
Düsseldorf 16
Shenyang 16
Trieste 16
London 14
Augusta 13
Hebei 13
Kraków 13
Lauterbourg 13
Redmond 13
Shanghai 13
Vienna 13
Kunming 12
Leawood 12
Rio de Janeiro 12
Turku 12
Abidjan 11
Belo Horizonte 11
Fremont 11
Guangzhou 11
Izmir 11
Santa Clara 11
Kish 10
Tianjin 10
Bexley 9
Changsha 9
Falkenstein 9
Montreal 9
Pune 9
Washington 9
Hanoi 8
Jiaxing 8
Mumbai 8
Portsmouth 8
Brescia 7
Lancaster 7
Paris 7
Piacenza 7
Simi Valley 7
Stockholm 7
Amsterdam 6
Andover 6
Colombo 6
Detroit 6
Jinan 6
Mexico City 6
Prague 6
Wroclaw 6
Baghdad 5
Curitiba 5
Totale 4.214
Salva come PNG Salva come JPEG
Nome #
Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. 359
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 244
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 242
Double pituitary adenomas 200
Predictors of morbidity and mortality in acromegaly, an Italian survey. 192
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 177
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 163
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 157
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 152
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 143
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 141
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 140
Assessment of neurological manifestations in hospitalized patients with COVID-19 137
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 124
Hypothalamitis: a diagnostic and therapeutic challenge 113
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 112
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 109
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 109
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 107
The Changing Clinical Spectrum of Hypophysitis 106
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 103
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 101
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 100
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 100
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 97
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 96
GH receptor isoforms and skeletal fragility in acromegaly 95
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 95
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 93
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 85
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 84
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 82
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 81
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 79
Spontaneous thyroid nodule hemorrhage in the emergency department 79
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 78
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 76
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 71
Vertebral fractures in males with prolactinoma. 70
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 70
Vertebral fractures in patients with acromegaly: a 3-year prospective study 70
Empty sella syndrome: Multiple endocrine disorders. 70
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 70
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 69
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 69
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 68
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 67
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 67
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 67
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 67
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 66
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 66
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 64
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 64
High prevalence of hyperplastic colonic polyps in acromegalic subjects. 62
Understanding the effect of acromegaly on the human skeleton. 62
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 62
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 61
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 61
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 60
Systemic mastocytosis mimicking carcinoid syndrome 60
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 58
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 57
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 57
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 56
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 55
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 53
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 53
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. 51
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 51
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 51
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 51
Neuropsychiatric symptoms, oral pigmentation and fever as revealing hints of autoimmune Addison’s disease 50
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 49
Acromegaly can be cured by first-line pasireotide treatment? 49
Acromegaly in the elderly patients 49
Hypothalamitis and pituitary atrophy 49
Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. 46
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU 45
Diabetic neuropathy: a risk factor for severe COVID-19? 42
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 42
Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study 42
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 41
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 39
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 36
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 36
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 32
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 31
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 30
Letter: A Multicenter, Propensity Score- Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 29
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 27
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 26
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 26
De-escalation treatment with pasireotide for acromegaly: a long-term experience 26
LCM-RNAseq Highlights Intratumor Heterogeneity and a lncRNA Signature from Archival Tissues of GH-Secreting PitNETs 22
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience 22
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 22
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 20
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 20
Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study 19
Totale 7.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.903
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 0 0 0 0 0 0 0 51
2020/2021569 30 57 14 56 83 32 76 13 57 47 93 11
2021/2022774 29 44 10 73 87 34 21 130 26 49 110 161
2022/20231.720 193 228 140 272 101 236 98 142 182 24 65 39
2023/2024919 38 209 33 46 44 150 47 20 33 55 104 140
2024/20251.913 45 52 161 95 139 89 61 94 345 241 499 92
Totale 8.059